Table 4.
Accuracy of circulating tumor biomarkers for gastrointestinal stromal tumor recurrence (excluding duplicate studies and those with unclear number or fewer than 20 recurrences).
| Author, year | Biomarkers | Stage | Pre-op, post-op or time of recurrence | No. recurrence/total | Sensitivity for recurrence | Specificity for recurrence | NPV for recurrence | PPV for recurrence | HR for recurrence (95% CI) | Adjusted HR (95% CI) | Mean/Median recurrence-free survival |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RECURRENCE | |||||||||||
| Rawnaq; 2011 (76) | 12 microsatellite markers for loss of heterozygosity | Advanced or recurrent GIST | Post-op | 29/83 | 58% | 75% | N/A | N/A | N/A | N/A | N/A |
CI, Confidence interval; HR, hazard ratio; N/A, not applicable; NPV, negative predictive value; PPV, positive predictive value; post-op, post-operative; pre-op: pre-operative.